Clinical Trial Update: Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy [Phase 4]

View source ↗

Summary

Phase 4 trial comparing low-dose and intermediate-dose low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Venous Thrombosis
• Pulmonary Embolism

Drugs mentioned

• Low molecular weight heparin (low molecular weight heparin)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Deep Venous Thrombosis, Pulmonary Embolism | Phase 4 | Status: COMPLETED